Annual CAPEX
$383.00 K
-$296.00 K-43.59%
31 December 2023
Summary:
Vanda Pharmaceuticals annual capital expenditures is currently $383.00 thousand, with the most recent change of -$296.00 thousand (-43.59%) on 31 December 2023. During the last 3 years, it has fallen by -$1.41 million (-78.66%). VNDA annual CAPEX is now -98.49% below its all-time high of $25.37 million, reached on 31 December 2018.VNDA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$161.00 K
+$53.00 K+49.07%
30 September 2024
Summary:
Vanda Pharmaceuticals quarterly capital expenditures is currently $161.00 thousand, with the most recent change of +$53.00 thousand (+49.07%) on 30 September 2024. Over the past year, it has increased by +$137.00 thousand (+570.83%). VNDA quarterly CAPEX is now -99.36% below its all-time high of $25.07 million, reached on 30 June 2018.VNDA Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$529.00 K
+$137.00 K+34.95%
30 September 2024
Summary:
Vanda Pharmaceuticals TTM capital expenditures is currently $529.00 thousand, with the most recent change of +$137.00 thousand (+34.95%) on 30 September 2024. Over the past year, it has increased by +$136.00 thousand (+34.61%). VNDA TTM CAPEX is now -97.95% below its all-time high of $25.77 million, reached on 30 June 2018.VNDA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VNDA CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -43.6% | +570.8% | +34.6% |
| 3 y3 years | -78.7% | +1710.0% | -61.8% |
| 5 y5 years | -98.5% | -45.2% | -45.6% |
VNDA CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -78.7% | at low | -38.8% | +1710.0% | -61.8% | +56.0% |
| 5 y | 5 years | -98.5% | at low | -83.3% | +1710.0% | -70.5% | +56.0% |
| alltime | all time | -98.5% | +117.6% | -99.4% | +1710.0% | -98.0% | +515.1% |
Vanda Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $161.00 K(+49.1%) | $529.00 K(+34.9%) |
| June 2024 | - | $108.00 K(+1442.9%) | $392.00 K(+15.6%) |
| Mar 2024 | - | $7000.00(-97.2%) | $339.00 K(-11.5%) |
| Dec 2023 | $383.00 K(-43.6%) | $253.00 K(+954.2%) | $383.00 K(-2.5%) |
| Sept 2023 | - | $24.00 K(-56.4%) | $393.00 K(-24.0%) |
| June 2023 | - | $55.00 K(+7.8%) | $517.00 K(-21.1%) |
| Mar 2023 | - | $51.00 K(-80.6%) | $655.00 K(-3.5%) |
| Dec 2022 | $679.00 K(+23.0%) | $263.00 K(+77.7%) | $679.00 K(+23.5%) |
| Sept 2022 | - | $148.00 K(-23.3%) | $550.00 K(+40.3%) |
| June 2022 | - | $193.00 K(+157.3%) | $392.00 K(-21.1%) |
| Mar 2022 | - | $75.00 K(-44.0%) | $497.00 K(-10.0%) |
| Dec 2021 | $552.00 K(-69.2%) | $134.00 K(-1440.0%) | $552.00 K(-60.1%) |
| Sept 2021 | - | -$10.00 K(-103.4%) | $1.38 M(-15.6%) |
| June 2021 | - | $298.00 K(+129.2%) | $1.64 M(+5.7%) |
| Mar 2021 | - | $130.00 K(-86.5%) | $1.55 M(-13.5%) |
| Dec 2020 | $1.79 M(+76.2%) | $966.00 K(+292.7%) | $1.79 M(+100.1%) |
| Sept 2020 | - | $246.00 K(+17.1%) | $897.00 K(-5.1%) |
| June 2020 | - | $210.00 K(-43.7%) | $945.00 K(-5.4%) |
| Mar 2020 | - | $373.00 K(+448.5%) | $999.00 K(-2.0%) |
| Dec 2019 | $1.02 M(-96.0%) | $68.00 K(-76.9%) | $1.02 M(+4.7%) |
| Sept 2019 | - | $294.00 K(+11.4%) | $973.00 K(+19.4%) |
| June 2019 | - | $264.00 K(-32.8%) | $815.00 K(-96.8%) |
| Mar 2019 | - | $393.00 K(+1686.4%) | $25.63 M(+1.0%) |
| Dec 2018 | $25.37 M(+1424.5%) | $22.00 K(-83.8%) | $25.37 M(-0.7%) |
| Sept 2018 | - | $136.00 K(-99.5%) | $25.54 M(-0.9%) |
| June 2018 | - | $25.07 M(>+9900.0%) | $25.77 M(+1850.9%) |
| Mar 2018 | - | $135.00 K(-29.3%) | $1.32 M(-20.6%) |
| Dec 2017 | $1.66 M | $191.00 K(-48.5%) | $1.66 M(-23.3%) |
| Sept 2017 | - | $371.00 K(-40.5%) | $2.17 M(-9.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | $624.00 K(+30.5%) | $2.40 M(+27.2%) |
| Mar 2017 | - | $478.00 K(-31.4%) | $1.89 M(+34.0%) |
| Dec 2016 | $1.41 M(-44.3%) | $697.00 K(+16.4%) | $1.41 M(-1.2%) |
| Sept 2016 | - | $599.00 K(+439.6%) | $1.42 M(-16.2%) |
| June 2016 | - | $111.00 K(-84.5%) | $1.70 M(-32.8%) |
| Dec 2015 | $2.53 M(-71.2%) | $714.00 K(-18.3%) | $2.53 M(+17.5%) |
| Sept 2015 | - | $874.00 K(+460.3%) | $2.15 M(+61.7%) |
| June 2015 | - | $156.00 K(-80.1%) | $1.33 M(-6.1%) |
| Mar 2015 | - | $783.00 K(+131.7%) | $1.42 M(-83.8%) |
| Dec 2014 | $8.77 M(+4882.4%) | $338.00 K(+537.7%) | $8.77 M(+2.8%) |
| Sept 2014 | - | $53.00 K(-78.2%) | $8.53 M(+0.5%) |
| June 2014 | - | $243.00 K(-97.0%) | $8.48 M(+2.3%) |
| Mar 2014 | - | $8.13 M(+8286.6%) | $8.29 M(+4609.1%) |
| Dec 2013 | $176.00 K(-91.3%) | $97.00 K(+1285.7%) | $176.00 K(+104.7%) |
| Sept 2013 | - | $7000.00(-85.7%) | $86.00 K(-10.4%) |
| June 2013 | - | $49.00 K(+113.0%) | $96.00 K(-50.8%) |
| Mar 2013 | - | $23.00 K(+228.6%) | $195.00 K(-90.3%) |
| Dec 2012 | $2.02 M(+633.5%) | $7000.00(-58.8%) | $2.02 M(-3.4%) |
| Sept 2012 | - | $17.00 K(-88.5%) | $2.09 M(-0.8%) |
| June 2012 | - | $148.00 K(-92.0%) | $2.10 M(-0.8%) |
| Mar 2012 | - | $1.84 M(+2296.1%) | $2.12 M(+670.9%) |
| Dec 2011 | $275.00 K(-97.7%) | $77.00 K(+126.5%) | $275.00 K(+38.9%) |
| Sept 2011 | - | $34.00 K(-79.3%) | $198.00 K(+20.7%) |
| June 2011 | - | $164.00 K(-96.7%) | $164.00 K(-96.7%) |
| Dec 2009 | $12.00 M(+1171.6%) | $5.00 M | $5.00 M |
| Dec 2008 | $943.70 K(+237.8%) | - | - |
| Dec 2007 | $279.40 K(-79.4%) | - | - |
| Dec 2006 | $1.35 M(+363.8%) | - | - |
| Dec 2005 | $292.00 K(-29.6%) | - | - |
| Dec 2004 | $414.50 K | - | - |
FAQ
- What is Vanda Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals annual CAPEX year-on-year change?
- What is Vanda Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals quarterly CAPEX year-on-year change?
- What is Vanda Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals TTM CAPEX year-on-year change?
What is Vanda Pharmaceuticals annual capital expenditures?
The current annual CAPEX of VNDA is $383.00 K
What is the all time high annual CAPEX for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high annual capital expenditures is $25.37 M
What is Vanda Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, VNDA annual capital expenditures has changed by -$296.00 K (-43.59%)
What is Vanda Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of VNDA is $161.00 K
What is the all time high quarterly CAPEX for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high quarterly capital expenditures is $25.07 M
What is Vanda Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, VNDA quarterly capital expenditures has changed by +$137.00 K (+570.83%)
What is Vanda Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of VNDA is $529.00 K
What is the all time high TTM CAPEX for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high TTM capital expenditures is $25.77 M
What is Vanda Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, VNDA TTM capital expenditures has changed by +$136.00 K (+34.61%)